Drug Shortage Report for ACT METHYLPHENIDATE ER

Last updated on 2020-04-23 History
Report ID 65996
Drug Identification Number 02441950
Brand name ACT METHYLPHENIDATE ER
Common or Proper name METHYLPHENIDATE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 36MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-12-01
Actual start date 2018-12-01
Estimated end date 2020-08-31
Actual end date
Shortage status Actual shortage
Updated date 2020-04-23
Company comments Inventory will be managed and allocated for 100% of regular demand. Estimated run out will be late February. Previous EED of 04/30/20 was an entry error and has been corrected.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2020-04-23 French Compare
v25 2020-04-23 English Compare
v24 2020-03-05 French Compare
v23 2020-03-05 English Compare
v22 2020-02-07 French Compare
v21 2020-02-07 English Compare
v20 2020-01-17 French Compare
v19 2020-01-17 English Compare
v18 2020-01-09 French Compare
v17 2020-01-09 English Compare
v16 2019-11-21 French Compare
v15 2019-11-21 English Compare
v14 2019-10-10 French Compare
v13 2019-10-10 English Compare
v12 2019-10-10 French Compare
v11 2019-10-10 English Compare
v10 2019-10-10 French Compare
v9 2019-10-10 English Compare
v8 2019-08-22 French Compare
v7 2019-08-22 English Compare

Showing 1 to 20 of 26